Hims & Hers Health, Inc.
HIMSHims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 10, 2026
5dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
HIMS Earnings Report
EPS Est: $-0.07 | FQ end 2026-06 | Call: 2026-08-10 15:00:00
How HIMS's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is Hims & Hers Health, Inc.'s next FDA catalyst?→
Hims & Hers Health, Inc.'s (HIMS) next tracked catalyst is a Earnings expected August 10, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track HIMS biotech catalysts?→
Add HIMS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Hims & Hers Health, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.